Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory Neuropathy

March 8, 2018 updated by: Mayo Clinic

Pilot Study of Effects of Tai Chi Easy on Cancer Survivors Experiencing Neuropathy

This pilot clinical trial studies how well Tai Chi Easy works in treating cancer survivors with peripheral sensory neuropathy. Tai Chi Easy is a simple and repetitive form of exercise that consists of movements with meditation and may improve peripheral neuropathy symptoms among cancer survivors.

Study Overview

Detailed Description

PRIMARY OBJECTIVES:

I. Examine effects of Tai Chi Easy (TCEasy) exercise intervention on peripheral sensory neuropathy of cancer survivors who have chemotherapy compared with an educational control (EC) intervention.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I (TAI CHI EASY): Patients attend Tai Chi Easy class for 60 minutes once a week for 6 weeks. Patients also receive a DVD and exercise manual of Tai Chi Easy exercises and are encouraged to practice at home for 30 minutes most days per week for 6 weeks.

GROUP II (EDUCATIONAL CONTROL): Patients receive readings each week and attend a book club to discuss the readings for 60 minutes once a week for 6 weeks.

After completion of study, patients are followed up at 2 months.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1 month - 5 years following completion of cytotoxic chemotherapy treatment for any cancer, and are experiencing neuropathy
  • Self-report of >= 4 on the Peripheral Neuropathy Question

Exclusion Criteria:

  • Recurrence of cancer or other active cancer
  • Severe cachexia, dizziness, bone pain, or severe nausea (as judged by the investigator)
  • Uncontrolled diabetes, untreated hypothyroidism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group I (Tai Chi Easy)
Patients attend Tai Chi Easy class for 60 minutes once a week for 6 weeks. Patients also receive a DVD and exercise manual of Tai Chi Easy exercises and are encouraged to practice at home for 30 minutes most days per week for 6 weeks.
Ancillary studies
Receive Tai Chi Easy class, DVD, and exercise manual
Active Comparator: Group II (educational control)
Patients receive readings each week and attend a book club to discuss the readings for 60 minutes once a week for 6 weeks.
Ancillary studies
Receive readings and attend book club
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in peripheral sensory neuropathy, assessed by Peripheral Neuropathy Question, European Organization for Research and Treatment of Cancer (EORTC)-30, EORTC-Chemotherapy-induced peripheral neuropathy-20, and the modified Total Neuropathy Score
Time Frame: Baseline up to 2 months
Will be assessed with a simple t-test of mTNS means. Additional analyses of factors assessed will similarly be conducted (and overall analysis of variance when combining outcome variable assessment at the three time points, and models of factor contribution with logistic regression if appropriate).
Baseline up to 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in anxiety assessed by POMS Total Mood Disturbance dimensions (tension-anxiety)
Time Frame: Baseline up to 2 months
Baseline up to 2 months
Changes in body mass index assessed by weight and height
Time Frame: Baseline up to 2 months
Will be measured directly using standardized protocols with medical-quality calibrated balance scales.
Baseline up to 2 months
Changes in cognitive performance assessed by digit span and letter-number sequencing
Time Frame: Baseline up to 2 months
Baseline up to 2 months
Changes in depression assessed by Program Operations Manual System (POMS) Total Mood Disturbance dimensions (depression-dejection)
Time Frame: Baseline up to 2 months
Baseline up to 2 months
Changes in fatigue assessed by Fatigue Symptom Inventory
Time Frame: Baseline up to 2 months
Baseline up to 2 months
Changes in pain assessed by Medical Outcomes Study-Short Form 36
Time Frame: Baseline up to 2 months
Baseline up to 2 months
Changes in sleep quality assessed by Pittsburgh Sleep Quality Index and actigraph
Time Frame: Baseline up to 2 months
Baseline up to 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Donald Northfelt, Mayo Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Actual)

January 18, 2017

Study Completion (Actual)

January 18, 2017

Study Registration Dates

First Submitted

July 12, 2013

First Submitted That Met QC Criteria

November 4, 2013

First Posted (Estimate)

November 11, 2013

Study Record Updates

Last Update Posted (Actual)

March 12, 2018

Last Update Submitted That Met QC Criteria

March 8, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 12-007483 (Other Identifier: Mayo Clinic in Arizona)
  • P30CA015083 (U.S. NIH Grant/Contract)
  • NCI-2016-01373 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Survivor

Clinical Trials on Questionnaire Administration

3
Subscribe